Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 407-415

  Pascual, D W ^a   White, M D ^a   Larson, T ^a   Walters, N ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDRESSIN; BACTERIAL ANTIGEN; CELL ADHESION MOLECULE; COLONIZATION FACTOR ANTIGEN 1; L SELECTIN; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; FIMBRIA; IMMUNIZATION; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INTESTINE MUCOSA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PROTEIN INTERACTION; SALMONELLA;

EID: 0035399591     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.407     Document Type: Article

References (50)

1. The mucosal immune system
2. New perspectives in vaccine development: Mucosal immunity to infections
3. 7 Integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
4. 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: The multistep model confirmed and refined
5. 4 integrins in lymphocyte homing to mucosal tissue in vivo
6. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor
7. A cell surface molecule involved in organ-specific homing of lymphocytes
8. 7): A functional role in Peyer's patch-specific lymphocyte homing
9. L-selectin mediated lymphocyte rolling on MAdCAM-1
10. Homing receptors reexamined: Mouse LECAM-1 (MEL-14 antigen) is involved in lymphocyte migration into gut-associated lymphoid tissue
11. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice
12. 7 integrin
13. 7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes
14. Nasal-associated lymphoid tissue (NALT): Phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to HEV in a mucosal site
15. Optimizing oral vaccines: Induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant
16. Selective induction of Th2 cells in murine Peyer's patches by oral immunization
17. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues
18. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses
19. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
20. Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen 1 (CFA/I) of enterotoxigenic E. coli (ETEC) in the absence of the CFA/I positive regulator cfaR
21. Induction of mucosal and systemic responses against human immunodeficiency virus type-1 gp120 in mice after oral immunization with a single dose of a Salmonella-HIV vector
22. - Salmonella vaccines
23. Salmonella typhimurium induces IFN-γ production in murine splenocytes: Role of natural killer cells and macrophages
24. Oral immunization with a Salmonella vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity
25. Expression of recombinant enterotoxigenic colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response
26. Further characterization of ΔaroA ΔvirG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli
27. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector
28. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine
29. Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major
30. Recombinant viruses as vectors for mucosal immunity
31. Selective delivery of antigens by recombinant bacteria
32. Live oral avirulent Salmonella vaccines
33. Salmonella as carriers of heterologous antigens
34. Impaired primary T cell responses in L-selectin-deficient mice
35. The route of antigen entry determines the requirement for L-selectin during immune responses
36. Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment
37. Humoral immune responses in L-selectin-deficient mice
38. Expression of L-selectin on Th1 cells is regulated by IL-12
39. Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by ΔaroC, ΔaroD Salmonella typhi vaccine strain CVD 908
40. Purification and analysis of colonization factor antigen 1, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli
41. Toxicity of lipopolysaccharide and of soluble extracts of Salmonella typhimurium in mice immunized with a live attenuated aroA Salmonella vaccine
42. Low-dose chymotrypsin treatment inhibits neutrophil migration into sites of inflammation in vivo: Effects on Mac-1 and MEL-14 adhesion protein expression and function
43. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody
44. The role of endogenous IL-18 in resolving wild-type and attenuated Salmonella typhimurium infections
45. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites
46. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways
47. Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide)
48. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers
49. Pre-clinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli
50. Role for L-selectin in lipopolysaccharide-induced activation of neutrophils